Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis-Reference-Cited by-同舟云学术

Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis

Published:2011-09 Issue:5 Volume:4 Page:319-332
ISSN:1756-2856
Container-title:Therapeutic Advances in Neurological Disorders
language:en
Short-container-title:Ther Adv Neurol Disord

Author:

Boster Aaron¹,Bartoszek Mary Pat²,O’Connell Colleen²,Pitt David³,Racke Michael³

Affiliation:

1. Multiple Sclerosis Center, Department of Neurology The Ohio State University Medical Center 395 West 12th Avenue, 7th floor Columbus, OH 43210, USA

2. Multiple Sclerosis Center, Department of Neurology, The Ohio State University Medical Center, Columbus, OH, USA

3. Multiple Sclerosis Center, Department of Neurology, and Department of Neuroscience, The Ohio State University Medical Center, Columbus, OH, USA

Publisher

SAGE Publications

Subject

Clinical Neurology,Neurology,Pharmacology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1756285611422108

Reference80 articles.

1. Effect of a synthetic polypeptide (Cop 1) on patients with multiple sclerosis and with acute disseminated encephalomyelitis

2. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice

3. Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking

4. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis

5. Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: Reversal by glatiramer acetate

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunopathogenesis of multiple sclerosis: molecular and cellular mechanisms and new immunotherapeutic approaches;Immunopharmacology and Immunotoxicology;2024-04-18

2. Neue Therapieansätze bei Multipler Sklerose inkl. Stellenwert älterer Präparate;Fortschritte der Neurologie · Psychiatrie;2024-01

3. Amyloid Precursor Protein and Tau Peptides Linked Together Ameliorate Loss of Cognition in an Alzheimer’s Disease Animal Model;International Journal of Molecular Sciences;2023-08-07

4. Drug‐induced liver injury by glatiramer acetate leading to liver transplant: A case report;JGH Open;2023-07-26

5. Neue Therapieansätze bei Multipler Sklerose inkl. Stellenwert älterer Präparate;Neurologie up2date;2023-06